“Insulin injections remain a daily burden for many patients,” said Associate Professor Shingo Ito. “Our peptide-based ...
11d
Biomea Fusion Details Diabetes, Obesity Pipeline at Citizens Conference, Sees Cash Runway to Q1 2027
Biomea Fusion (NASDAQ:BMEA) outlined its focus on diabetes and obesity at the Citizens Life Sciences Conference, highlighting ...
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies ...
In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk for macrosomia than clinician-led approaches.
A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need, and how much they spend on it. In a new analysis published ...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...
The updated labeling provides a new conversion chart for starting dosages when switching patients from subcutaneous mealtime insulin to Afrezza. The Food and Administration (FDA) has approved updated ...
A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats. (Nanowerk Spotlight) An ...
Medtronic plans to launch the MiniMed Go app this spring. The company said the feature helps people using insulin pens with glycemic control. A retrospective analysis found the average time in range, ...
Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results